1. INTRODUCTION 1.1. REPORT DESCRIPTION 1.2. RESEARCH METHODOLOGY 1.2.1 SECONDARY RESEARCH 1.2.2 DATA ANALYSIS FRAMEWORK 1.2.3 MARKET SIZE ESTIMATION 1.2.4 FORECASTING 1.2.5 PRIMARY RESEARCH AND DATA VALIDATION 2. MARKET SNAPSHOT, 2019-2030 MILLION USD 2.1. MARKET SNAPSHOT 3. PORTER’S FIVE FORCE MODEL ANALYSIS 4. MARKET DYNAMICS 4.1. GROWTH DRIVERS 4.1.1 DRIVER 1 4.1.2 DRIVER 2 4.1.3 DRIVER 3 4.1.4 DRIVER 4 4.2. CHALLENGES 4.2.1 CHALLENGE 1 4.2.2 CHALLENGE 2 4.3. OPPORTUNITIES 4.3.1 OPPORTUNITY 1 4.3.2 OPPORTUNITY 2 5. GLOBAL NEUROMODULATION MARKET, BY TECHNOLOGY 5.1. OVERVIEW 5.2. INTERNAL NEUROMODULATION 5.2.1 GLOBAL INTERNAL NEUROMODULATION MARKET, BY TECHNOLOGY 5.2.1.1 Deep Brain Stimulation Market, By Region 5.2.1.1.1 North America Deep Brain Stimulation Market, By Country 5.2.1.1.2 Europe Deep Brain Stimulation Market, By Country 5.2.1.1.3 Asia-Pacific Deep Brain Stimulation Market, By Country 5.2.1.1.4 Rest of World Deep Brain Stimulation Market, By Country 5.2.1.2 Sacral nerve Stimulation Market, By Region 5.2.1.2.1 North America Sacral nerve Stimulation Market, By Country 5.2.1.2.2 Europe Sacral nerve Stimulation Market, By Country 5.2.1.2.3 Asia-Pacific Sacral nerve Stimulation Market, By Country 5.2.1.2.4 Rest of World Sacral nerve Stimulation Market, By Country 5.2.1.3 Spinal Cord Stimulation Market, By Region 5.2.1.3.1 North America Spinal Cord Stimulation Market, By Country 5.2.1.3.2 Europe Spinal Cord Stimulation Market, By Country 5.2.1.3.3 Asia-Pacific Spinal Cord Stimulation Market, By Country 5.2.1.3.4 Rest of World Spinal Cord Stimulation Market, By Country 5.2.1.4 Vagus Nerve Stimulation Market, By Region 5.2.1.4.1 North America Vagus Nerve Stimulation Market, By Country 5.2.1.4.2 Europe Vagus Nerve Stimulation Market, By Country 5.2.1.4.3 Asia-Pacific Vagus Nerve Stimulation Market, By Country 5.2.1.4.4 Rest of World Vagus Nerve Stimulation Market, By Country 5.2.1.5 Other Neuromodulation Market, By Region 5.2.1.5.1 North America Other Neuromodulation Market, By Country 5.2.1.5.2 Europe Other Neuromodulation Market, By Country 5.2.1.5.3 Asia-Pacific Other Neuromodulation Market, By Country 5.2.1.5.4 Rest of World Other Neuromodulation Market, By Country 5.2.2 INTERNAL NEUROMODULATION MARKET, BY REGION 5.2.2.1 North America Internal Neuromodulation Market, By Country 5.2.2.2 Europe Internal Neuromodulation Market, By Country 5.2.2.3 Asia-Pacific Internal Neuromodulation Market, By Country 5.2.2.4 Rest of World Internal Neuromodulation Market, By Country 5.3. EXTERNAL NEUROMODULATION 5.3.1 GLOBAL EXTERNAL NEUROMODULATION MARKET, BY TECHNOLOGY 5.3.1.1 Transcutaneous Electrical Nerve Stimulation Market, By Region 5.3.1.1.1 North America Transcutaneous Electrical Nerve Stimulation Market, By Country 5.3.1.1.2 Europe Transcutaneous Electrical Nerve Stimulation Market, By Country 5.3.1.1.3 Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market, By Country 5.3.1.1.4 Rest of World Transcutaneous Electrical Nerve Stimulation Market, By Country 5.3.1.2 Transcranial Magnetic Stimulation Market, By Region 5.3.1.2.1 North America Transcranial Magnetic Stimulation Market, By Country 5.3.1.2.2 Europe Transcranial Magnetic Stimulation Market, By Country 5.3.1.2.3 Asia-Pacific Transcranial Magnetic Stimulation Market, By Country 5.3.1.2.4 Rest of World Transcranial Magnetic Stimulation Market, By Country 5.3.2 EXTERNAL NEUROMODULATION MARKET, BY REGION 5.3.2.1 North America External Neuromodulation Market, By Country 5.3.2.2 Europe External Neuromodulation Market, By Country 5.3.2.3 Asia-Pacific External Neuromodulation Market, By Country 5.3.2.4 Rest of World External Neuromodulation Market, By Country 6. GLOBAL NEUROMODULATION MARKET, BY APPLICATION 6.1. OVERVIEW 6.2. FAILED BACK SYNDROME 6.2.1 FAILED BACK SYNDROME MARKET, BY REGION 6.2.1.1 North America Failed Back Syndrome Market, By Country 6.2.1.2 Europe Failed Back Syndrome Market, By Country 6.2.1.3 Asia-Pacific Failed Back Syndrome Market, By Country 6.2.1.4 Rest of World Failed Back Syndrome Market, By Country 6.3. CHRONIC PAIN 6.3.1 CHRONIC PAIN MARKET, BY REGION 6.3.1.1 North America Chronic Pain Market, By Country 6.3.1.2 Europe Chronic Pain Market, By Country 6.3.1.3 Asia-Pacific Chronic Pain Market, By Country 6.3.1.4 Rest of World Chronic Pain Market, By Country 6.4. EPILEPSY 6.4.1 EPILEPSY MARKET, BY REGION 6.4.1.1 North America Epilepsy Market, By Country 6.4.1.2 Europe Epilepsy Market, By Country 6.4.1.3 Asia-Pacific Epilepsy Market, By Country 6.4.1.4 Rest of World Epilepsy Market, By Country 6.5. ESSENTIAL TREMOR 6.5.1 ESSENTIAL TREMOR MARKET, BY REGION 6.5.1.1 North America Essential Tremor Market, By Country 6.5.1.2 Europe Essential Tremor Market, By Country 6.5.1.3 Asia-Pacific Essential Tremor Market, By Country 6.5.1.4 Rest of World Essential Tremor Market, By Country 6.6. URINARY AND FECAL INCONTINENCE 6.6.1 URINARY AND FECAL INCONTINENCE MARKET, BY REGION 6.6.1.1 North America Urinary and Fecal Incontinence Market, By Country 6.6.1.2 Europe Urinary and Fecal Incontinence Market, By Country 6.6.1.3 Asia-Pacific Urinary and Fecal Incontinence Market, By Country 6.6.1.4 Rest of World Urinary and Fecal Incontinence Market, By Country 6.7. DEPRESSION 6.7.1 DEPRESSION MARKET, BY REGION 6.7.1.1 North America Depression Market, By Country 6.7.1.2 Europe Depression Market, By Country 6.7.1.3 Asia-Pacific Depression Market, By Country 6.7.1.4 Rest of World Depression Market, By Country 6.8. DYSTONIA 6.8.1 DYSTONIA MARKET, BY REGION 6.8.1.1 North America Dystonia Market, By Country 6.8.1.2 Europe Dystonia Market, By Country 6.8.1.3 Asia-Pacific Dystonia Market, By Country 6.8.1.4 Rest of World Dystonia Market, By Country 6.9. GASTROPARESIS 6.9.1 GASTROPARESIS MARKET, BY REGION 6.9.1.1 North America Gastroparesis Market, By Country 6.9.1.2 Europe Gastroparesis Market, By Country 6.9.1.3 Asia-Pacific Gastroparesis Market, By Country 6.9.1.4 Rest of World Gastroparesis Market, By Country 6.10. PARKINSON'S DISEASE 6.10.1 PARKINSON'S DISEASE MARKET, BY REGION 6.10.1.1 North America Parkinson's Disease Market, By Country 6.10.1.2 Europe Parkinson's Disease Market, By Country 6.10.1.3 Asia-Pacific Parkinson's Disease Market, By Country 6.10.1.4 Rest of World Parkinson's Disease Market, By Country 6.11. MIGRAINE 6.11.1 MIGRAINE MARKET, BY REGION 6.11.1.1 North America Migraine Market, By Country 6.11.1.2 Europe Migraine Market, By Country 6.11.1.3 Asia-Pacific Migraine Market, By Country 6.11.1.4 Rest of World Migraine Market, By Country 7. GLOBAL NEUROMODULATION MARKET, BY BIOMATERIAL 7.1. OVERVIEW 7.2. CERAMICS BIOMATERIALS 7.2.1 CERAMICS BIOMATERIALS MARKET, BY REGION 7.2.1.1 North America Ceramics Biomaterials Market, By Country 7.2.1.2 Europe Ceramics Biomaterials Market, By Country 7.2.1.3 Asia-Pacific Ceramics Biomaterials Market, By Country 7.2.1.4 Rest of World Ceramics Biomaterials Market, By Country 7.3. METALLIC BIOMATERIALS 7.3.1 METALLIC BIOMATERIALS MARKET, BY REGION 7.3.1.1 North America Metallic Biomaterials Market, By Country 7.3.1.2 Europe Metallic Biomaterials Market, By Country 7.3.1.3 Asia-Pacific Metallic Biomaterials Market, By Country 7.3.1.4 Rest of World Metallic Biomaterials Market, By Country 7.4. POLYMERIC BIOMATERIALS 7.4.1 POLYMERIC BIOMATERIALS MARKET, BY REGION 7.4.1.1 North America Polymeric Biomaterials Market, By Country 7.4.1.2 Europe Polymeric Biomaterials Market, By Country 7.4.1.3 Asia-Pacific Polymeric Biomaterials Market, By Country 7.4.1.4 Rest of World Polymeric Biomaterials Market, By Country 8. GLOBAL NEUROMODULATION MARKET, BY REGION 8.1. OVERVIEW 8.2. NORTH AMERICA 8.2.1 NORTH AMERICA NEUROMODULATION MARKET, BY TECHNOLOGY 8.2.1.1 North America Internal Neuromodulation Market, By Technology 8.2.1.2 North America External Neuromodulation Market, By Technology 8.2.2 NORTH AMERICA NEUROMODULATION MARKET, BY APPLICATION 8.2.3 NORTH AMERICA NEUROMODULATION MARKET, BY BIOMATERIAL 8.2.4 NORTH AMERICA NEUROMODULATION, MARKET BY COUNTRY 8.2.4.1 U.S. 8.2.4.1.1 U.S. Neuromodulation Market, By Technology 8.2.4.1.1.1. U.S. Internal Neuromodulation Market, By Technology 8.2.4.1.1.2. U.S. External Neuromodulation Market, By Technology 8.2.4.1.2 U.S. Neuromodulation Market, By Application 8.2.4.1.3 U.S. Neuromodulation Market, By Biomaterial 8.2.4.2 Canada 8.2.4.2.1 Canada Neuromodulation Market, By Technology 8.2.4.2.1.1. Canada Internal Neuromodulation Market, By Technology 8.2.4.2.1.2. Canada External Neuromodulation Market, By Technology 8.2.4.2.2 Canada Neuromodulation Market, By Application 8.2.4.2.3 Canada Neuromodulation Market, By Biomaterial 8.2.4.3 Mexico 8.2.4.3.1 Mexico Neuromodulation Market, By Technology 8.2.4.3.1.1. Mexico Internal Neuromodulation Market, By Technology 8.2.4.3.1.2. Mexico External Neuromodulation Market, By Technology 8.2.4.3.2 Mexico Neuromodulation Market, By Application 8.2.4.3.3 Mexico Neuromodulation Market, By Biomaterial 8.3. EUROPE 8.3.1 EUROPE NEUROMODULATION MARKET, BY TECHNOLOGY 8.3.1.1 Europe Internal Neuromodulation Market, By Technology 8.3.1.2 Europe External Neuromodulation Market, By Technology 8.3.2 EUROPE NEUROMODULATION MARKET, BY APPLICATION 8.3.3 EUROPE NEUROMODULATION MARKET, BY BIOMATERIAL 8.3.4 EUROPE NEUROMODULATION, MARKET BY COUNTRY 8.3.4.1 Germany 8.3.4.1.1 Germany Neuromodulation Market, By Technology 8.3.4.1.1.1. Germany Internal Neuromodulation Market, By Technology 8.3.4.1.1.2. Germany External Neuromodulation Market, By Technology 8.3.4.1.2 Germany Neuromodulation Market, By Application 8.3.4.1.3 Germany Neuromodulation Market, By Biomaterial 8.3.4.2 UK 8.3.4.2.1 UK Neuromodulation Market, By Technology 8.3.4.2.1.1. UK Internal Neuromodulation Market, By Technology 8.3.4.2.1.2. UK External Neuromodulation Market, By Technology 8.3.4.2.2 UK Neuromodulation Market, By Application 8.3.4.2.3 UK Neuromodulation Market, By Biomaterial 8.3.4.3 France 8.3.4.3.1 France Neuromodulation Market, By Technology 8.3.4.3.1.1. France Internal Neuromodulation Market, By Technology 8.3.4.3.1.2. France External Neuromodulation Market, By Technology 8.3.4.3.2 France Neuromodulation Market, By Application 8.3.4.3.3 France Neuromodulation Market, By Biomaterial 8.3.4.4 Italy 8.3.4.4.1 Italy Neuromodulation Market, By Technology 8.3.4.4.1.1. Italy Internal Neuromodulation Market, By Technology 8.3.4.4.1.2. Italy External Neuromodulation Market, By Technology 8.3.4.4.2 Italy Neuromodulation Market, By Application 8.3.4.4.3 Italy Neuromodulation Market, By Biomaterial 8.3.4.5 Spain 8.3.4.5.1 Spain Neuromodulation Market, By Technology 8.3.4.5.1.1. Spain Internal Neuromodulation Market, By Technology 8.3.4.5.1.2. Spain External Neuromodulation Market, By Technology 8.3.4.5.2 Spain Neuromodulation Market, By Application 8.3.4.5.3 Spain Neuromodulation Market, By Biomaterial 8.3.4.6 Rest of Europe 8.3.4.6.1 Rest of Europe Neuromodulation Market, By Technology 8.3.4.6.1.1. Rest of Europe Internal Neuromodulation Market, By Technology 8.3.4.6.1.2. Rest of Europe External Neuromodulation Market, By Technology 8.3.4.6.2 Rest of Europe Neuromodulation Market, By Application 8.3.4.6.3 Rest of Europe Neuromodulation Market, By Biomaterial 8.4. ASIA-PACIFIC 8.4.1 ASIA-PACIFIC NEUROMODULATION MARKET, BY TECHNOLOGY 8.4.1.1 Asia-Pacific Internal Neuromodulation Market, By Technology 8.4.1.2 Asia-Pacific External Neuromodulation Market, By Technology 8.4.2 ASIA-PACIFIC NEUROMODULATION MARKET, BY APPLICATION 8.4.3 ASIA-PACIFIC NEUROMODULATION MARKET, BY BIOMATERIAL 8.4.4 ASIA-PACIFIC NEUROMODULATION, MARKET BY COUNTRY 8.4.4.1 China 8.4.4.1.1 China Neuromodulation Market, By Technology 8.4.4.1.1.1. China Internal Neuromodulation Market, By Technology 8.4.4.1.1.2. China External Neuromodulation Market, By Technology 8.4.4.1.2 China Neuromodulation Market, By Application 8.4.4.1.3 China Neuromodulation Market, By Biomaterial 8.4.4.2 India 8.4.4.2.1 India Neuromodulation Market, By Technology 8.4.4.2.1.1. India Internal Neuromodulation Market, By Technology 8.4.4.2.1.2. India External Neuromodulation Market, By Technology 8.4.4.2.2 India Neuromodulation Market, By Application 8.4.4.2.3 India Neuromodulation Market, By Biomaterial 8.4.4.3 Japan 8.4.4.3.1 Japan Neuromodulation Market, By Technology 8.4.4.3.1.1. Japan Internal Neuromodulation Market, By Technology 8.4.4.3.1.2. Japan External Neuromodulation Market, By Technology 8.4.4.3.2 Japan Neuromodulation Market, By Application 8.4.4.3.3 Japan Neuromodulation Market, By Biomaterial 8.4.4.4 South Korea 8.4.4.4.1 South Korea Neuromodulation Market, By Technology 8.4.4.4.1.1. South Korea Internal Neuromodulation Market, By Technology 8.4.4.4.1.2. South Korea External Neuromodulation Market, By Technology 8.4.4.4.2 South Korea Neuromodulation Market, By Application 8.4.4.4.3 South Korea Neuromodulation Market, By Biomaterial 8.4.4.5 Malaysia 8.4.4.5.1 Malaysia Neuromodulation Market, By Technology 8.4.4.5.1.1. Malaysia Internal Neuromodulation Market, By Technology 8.4.4.5.1.2. Malaysia External Neuromodulation Market, By Technology 8.4.4.5.2 Malaysia Neuromodulation Market, By Application 8.4.4.5.3 Malaysia Neuromodulation Market, By Biomaterial 8.4.4.6 Rest of Asia-Pacific 8.4.4.6.1 Rest of Asia-Pacific Neuromodulation Market, By Technology 8.4.4.6.1.1. Rest of Asia-Pacific Internal Neuromodulation Market, By Technology 8.4.4.6.1.2. Rest of Asia-Pacific External Neuromodulation Market, By Technology 8.4.4.6.2 Rest of Asia-Pacific Neuromodulation Market, By Application 8.4.4.6.3 Rest of Asia-Pacific Neuromodulation Market, By Biomaterial 8.5. REST OF WORLD 8.5.1 REST OF WORLD NEUROMODULATION MARKET, BY TECHNOLOGY 8.5.1.1 Rest of World Internal Neuromodulation Market, By Technology 8.5.1.2 Rest of World External Neuromodulation Market, By Technology 8.5.2 REST OF WORLD NEUROMODULATION MARKET, BY APPLICATION 8.5.3 REST OF WORLD NEUROMODULATION MARKET, BY BIOMATERIAL 8.5.4 REST OF WORLD NEUROMODULATION, MARKET BY COUNTRY 8.5.4.1 Brazil 8.5.4.1.1 Brazil Neuromodulation Market, By Technology 8.5.4.1.1.1. Brazil Internal Neuromodulation Market, By Technology 8.5.4.1.1.2. Brazil External Neuromodulation Market, By Technology 8.5.4.1.2 Brazil Neuromodulation Market, By Application 8.5.4.1.3 Brazil Neuromodulation Market, By Biomaterial 8.5.4.2 Israel 8.5.4.2.1 Israel Neuromodulation Market, By Technology 8.5.4.2.1.1. Israel Internal Neuromodulation Market, By Technology 8.5.4.2.1.2. Israel External Neuromodulation Market, By Technology 8.5.4.2.2 Israel Neuromodulation Market, By Application 8.5.4.2.3 Israel Neuromodulation Market, By Biomaterial 8.5.4.3 Saudi Arabia 8.5.4.3.1 Saudi Arabia Neuromodulation Market, By Technology 8.5.4.3.1.1. Saudi Arabia Internal Neuromodulation Market, By Technology 8.5.4.3.1.2. Saudi Arabia External Neuromodulation Market, By Technology 8.5.4.3.2 Saudi Arabia Neuromodulation Market, By Application 8.5.4.3.3 Saudi Arabia Neuromodulation Market, By Biomaterial 8.5.4.4 South Africa 8.5.4.4.1 South Africa Neuromodulation Market, By Technology 8.5.4.4.1.1. South Africa Internal Neuromodulation Market, By Technology 8.5.4.4.1.2. South Africa External Neuromodulation Market, By Technology 8.5.4.4.2 South Africa Neuromodulation Market, By Application 8.5.4.4.3 South Africa Neuromodulation Market, By Biomaterial 8.5.4.5 Remaining Countries 8.5.4.5.1 Remaining Countries Neuromodulation Market, By Technology 8.5.4.5.1.1. Remaining Countries Internal Neuromodulation Market, By Technology 8.5.4.5.1.2. Remaining Countries External Neuromodulation Market, By Technology 8.5.4.5.2 Remaining Countries Neuromodulation Market, By Application 8.5.4.5.3 Remaining Countries Neuromodulation Market, By Biomaterial 9. COMPANY PROFILES 9.1. ALEVA NEUROTHERAPEUTICS SA 9.1.1 COMPANY OVERVIEW 9.1.2 COMPANY SNAPSHOT 9.1.3 OPERATING BUSINESS SEGMENTS 9.1.4 PRODUCT PORTFOLIO 9.1.5 BUSINESS PERFORMANCE 9.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.2. BIOCONTROL MEDICAL 9.2.1 COMPANY OVERVIEW 9.2.2 COMPANY SNAPSHOT 9.2.3 OPERATING BUSINESS SEGMENTS 9.2.4 PRODUCT PORTFOLIO 9.2.5 BUSINESS PERFORMANCE 9.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.3. BIONESS INC. 9.3.1 COMPANY OVERVIEW 9.3.2 COMPANY SNAPSHOT 9.3.3 OPERATING BUSINESS SEGMENTS 9.3.4 PRODUCT PORTFOLIO 9.3.5 BUSINESS PERFORMANCE 9.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.4. BOSTON SCIENTIFIC CORPORATION 9.4.1 COMPANY OVERVIEW 9.4.2 COMPANY SNAPSHOT 9.4.3 OPERATING BUSINESS SEGMENTS 9.4.4 PRODUCT PORTFOLIO 9.4.5 BUSINESS PERFORMANCE 9.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.5. ENTEROMEDICS INC. 9.5.1 COMPANY OVERVIEW 9.5.2 COMPANY SNAPSHOT 9.5.3 OPERATING BUSINESS SEGMENTS 9.5.4 PRODUCT PORTFOLIO 9.5.5 BUSINESS PERFORMANCE 9.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.6. LIVANOVA PLC 9.6.1 COMPANY OVERVIEW 9.6.2 COMPANY SNAPSHOT 9.6.3 OPERATING BUSINESS SEGMENTS 9.6.4 PRODUCT PORTFOLIO 9.6.5 BUSINESS PERFORMANCE 9.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.7. MEDTRONIC PLC 9.7.1 COMPANY OVERVIEW 9.7.2 COMPANY SNAPSHOT 9.7.3 OPERATING BUSINESS SEGMENTS 9.7.4 PRODUCT PORTFOLIO 9.7.5 BUSINESS PERFORMANCE 9.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.8. NEUROPACE, INC. 9.8.1 COMPANY OVERVIEW 9.8.2 COMPANY SNAPSHOT 9.8.3 OPERATING BUSINESS SEGMENTS 9.8.4 PRODUCT PORTFOLIO 9.8.5 BUSINESS PERFORMANCE 9.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.9. NEVRO CORPORATION 9.9.1 COMPANY OVERVIEW 9.9.2 COMPANY SNAPSHOT 9.9.3 OPERATING BUSINESS SEGMENTS 9.9.4 PRODUCT PORTFOLIO 9.9.5 BUSINESS PERFORMANCE 9.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT 9.10. ST. JUDE MEDICAL, INC. 9.10.1 COMPANY OVERVIEW 9.10.2 COMPANY SNAPSHOT 9.10.3 OPERATING BUSINESS SEGMENTS 9.10.4 PRODUCT PORTFOLIO 9.10.5 BUSINESS PERFORMANCE 9.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT